Although several widely-used anti-rheumatic drugs, such as methotrexate, steroids, anti-IL-6R and anti-TNFa monoclonal antibodies, have demonstrated some degree of efficacy in the treatment of RA, a substantial proportion of patients exhibit poor response and the incidence of adverse reactions is substantial. Here, TNF is linked to rheumatoid arthritis.